Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Shaping the future of cell and gene therapy manufacturing at Advanced Therapies Europe 2024

The Advanced Therapies Europe 2024 conference in Estoril, Portugal, set the stage for crucial discussions about the future of cell and gene therapy (CGT) manufacturing. As the industry stands on the brink of scaling these innovative therapies to meet growing patient demand, the message was clear—automation and digitalisation are key to unlocking the next phase of growth.

This need was recognised at the event, with a major focus around how to bridge the gap between today’s manufacturing practices and the future vision of fully automated, digitally integrated processes. The conversations centred on simplifying processes to ensure scalability and affordability, while maintaining high quality.

As an attendee and speaker at Advanced Therapies Europe 2024, Dan Gibson, Head of Collaborations at the Cell and Gene Therapy Catapult, provides an overview of his takeaways from the event.

Published on the 30th of september 2024. Read the full news report following this link.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (19 novembre 2024). Shaping the future of cell and gene therapy manufacturing at Advanced Therapies Europe 2024. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/12prt


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.